| Literature DB >> 9559813 |
Abstract
The staphylococcal pentaglycine side chain of the peptidoglycan is reduced to one glycine in femAB null mutants. This is associated with increased susceptibility to methicillin and to a whole range of unrelated antibiotics as well. Genetic evidence suggests that femAB null mutants are only viable because of a compensatory mutation in an unlinked site.Entities:
Mesh:
Substances:
Year: 1998 PMID: 9559813 PMCID: PMC105572 DOI: 10.1128/AAC.42.4.936
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191